July 24, 2016 4:09 PM ET

Healthcare Providers and Services

Company Overview of Fox Chase Cancer Center

Company Overview

Fox Chase Cancer Center owns and operates a cancer care hospital in Philadelphia. It offers surgery, radiation oncology, virtual colonoscopy, diagnostic imaging, and breast imaging center of excellence seal services; and develops various therapies and technologies for treating cancer. The company also provides breast evaluation, risk assessment, and cancer education services; and conducts basic, translational, and clinical research with special programs in cancer prevention, detection, survivorship, and community outreach. In addition, it offers fellowship training in breast cancer, hematology, pathology, surgical oncology, advanced minimally invasive thoracic surgery, and urologic oncology....

333 Cottman Avenue

Philadelphia, PA 19111-2497

United States

Founded in 1904





Key Executives for Fox Chase Cancer Center

Chief Executive Officer, President and Cancer Center Director
Chief Financial Officer
Chief Operating Officer
President of Friends of The Hospital
President of Fox Chase Chapter
Compensation as of Fiscal Year 2016.

Fox Chase Cancer Center Key Developments

Fox Chase Cancer Center Signs an Agreement with Universal Hospital in Abu Dhabi to Design Program Services for a Bone Marrow Transplant Program

Fox Chase Cancer Center signed an agreement with Universal Hospital in Abu Dhabi to design program services for a bone marrow transplant program Universal plans to establish within the United Arab Emirates. The agreement is a follow-up to a memorandum of understanding, outlining plans for the hospitals to collaborate on projects, the two organizations signed in November. As part of the partnership, Universal Hospital plans to establish exchange programs and customized physician programs at Fox Chase's affiliated hospitals in the Philadelphia region.

Fox Chase Report Earnings Results for the Year Ended June 30, 2015

Fox Chase reported earnings results for the year ended June 30, 2015. For the year, the company had an operating profit of $11.3 million in the year ended June 30 compared to an $18.5 million operating loss the year before.

Horizon Pharma plc Announces Collaboration with Fox Chase Cancer Center to Study ACTIMMUNE (interferon Gamma 1b) in Combination with PD-1/PD-L1 Inhibitors in Various Forms of Cancer

Horizon Pharma plc announced a collaboration with Fox Chase Cancer Center to study ACTIMMUNE (interferon gamma-1b) in combination with PD-1/PD-L1 inhibitors in various forms of cancer including advanced urothelial carcinoma (bladder cancer) and renal cell carcinoma. Preclinical cell line research has indicated that interferon gamma enhances cellular PD-L1 expression on endothelial cells (inner lining of the blood vessel) and on some tumor cells. By enhancing cellular PD-L1 expression on tumor cells, interferon gamma may promote or enhance the effect of the PD-1 or PD-L1 inhibitors. The first study being planned as part of the collaboration will be a dose-ranging study to determine a suitable dose for ACTIMMUNE with PD-1/PD-L1 inhibition. Once the ideal combination strategy is determined, the investigators intend to expand the study to include patients with metastatic bladder and renal cell carcinomas. Additional studies are expected to follow depending on initial results.

Similar Private Companies By Industry

Company Name Region
@ Home Medical, Inc. United States
@home approach, llc United States
@Home Care United States
1011 E. Pecan Grove Road, LLC United States
1125 Sir Francis Drake Boulevard Operating Company, Llc United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Bloomberg L.P. United States
NYC2012, Inc. United States
Rush University United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Fox Chase Cancer Center, please visit www.fccc.edu. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.